US 11,918,456 B2
Devices and methods for implanting corneal tissue
Jerry W. Barker, Gretna, VA (US); Douglas C. Drabble, Winston-Salem, NC (US); Timothy G. Baldwin, Winston-Salem, NC (US); and Yousuf Khalifa, Smyrna, GA (US)
Assigned to CorneaGen, Seattle, WA (US)
Filed by CorneaGen Inc., Seattle, WA (US)
Filed on Apr. 26, 2021, as Appl. No. 17/240,755.
Application 17/240,755 is a continuation of application No. 15/912,990, filed on Mar. 6, 2018, granted, now 10,987,212.
Claims priority of provisional application 62/467,319, filed on Mar. 6, 2017.
Prior Publication US 2021/0315686 A1, Oct. 14, 2021
Int. Cl. A61F 2/14 (2006.01); A61B 17/00 (2006.01); A61B 17/29 (2006.01); A61B 17/30 (2006.01); A61F 9/007 (2006.01)
CPC A61F 2/148 (2013.01) [A61F 2/142 (2013.01); A61F 9/007 (2013.01); A61B 2017/00544 (2013.01); A61B 2017/00969 (2013.01); A61B 2017/2932 (2013.01); A61B 2017/305 (2013.01)] 14 Claims
OG exemplary drawing
 
1. A method for operating a tissue manipulation device, comprising:
operating a first actuator on a handle of the tissue manipulation device to cause forceps to engage a corneal implant, the forceps being disposed at an end of a guide extending from the handle;
extending the guide into an eye and positioning the corneal implant at an implant site at a corneal posterior;
operating a second actuator on the handle of the tissue manipulation device to deliver air to the corneal implant from an air chamber disposed in an interior chamber of the handle, the air being delivered via an air channel coupled to the air chamber and extending along the guide to the end; and
operating the first actuator to release the corneal implant from the forceps.